COVID-19 vaccination campaigns and health outcomes in Spain during 2021

References

• Andrés, J., J. E. Boscá, R. Doménech, and J. Ferri. 2020. “Bienestar Social y COVID-19”. Nada es Gratis. https://nadaesgratis.es/javier-ferri/bienestar-social-y-covid-19https://cutt.ly/m3zxdoj
   Google Scholar
• Arbel, R. S., R. Friger, M. Peretz, A. Beckenstein, T. Yaron, S. Netzer, A. Hammerman, and A. Hammerman. 2022. “Effectiveness of a Second BNT162b2 Booster Vaccine Against Hospitalization and Death from COVID-19 in Adults Aged Over 60 Years.” Nature Medicine 28 (7): 1486–1490. doi:10.1038/s41591-022-01832-0.
   PubMed Web of Science ®Google Scholar
• Barro, R. J. 2022. “Vaccination Rates and COVID Outcomes Across U.S. States”. NBER Working Paper 29884. National Bureau of Economic Research.
   Google Scholar
• Birenbaum-Carmeli, D., and J. Chassida. 2021. “Health and Socio-Demographic Implications of the COVID-19 Second Pandemic Wave in Israel, Compared with the First Wave.” International Journal for Equity in Health 20 (1): 1–12. doi:10.1186/s12939-021-01445-y.
   PubMed Web of Science ®Google Scholar
• Centro de Coordinación de Alertas y Emergencias Sanitarias. 2021a. Actualizaciones diarias. Enfermedad por el coronavirus (COVID-19). No 529. Table 10. https://rb.gy/cewkll
   Google Scholar
• Centro de Coordinación de Alertas y Emergencias Sanitarias. 2021b. Actualizaciones diarias. Enfermedad por el coronavirus (COVID-19). N 282 a 533. https://rb.gy/vdria9 to https://rb.gy/wbz84i
   Google Scholar
• Centro de Coordinación de Alertas y Emergencias Sanitarias. 2021c. Datos abiertos de la capacidad asistencial. https://rb.gy/wiqwfw
   Google Scholar
• Chen, M., Y. Yuan, Y. Zhou, Z. Deng, J. Zhao, F. Feng, H. Zou, and C. Sun. 2021. “Safety of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Infectious Diseases of Poverty 10 (1): 1–12. doi:10.1186/s40249-021-00878-5.
   PubMed Web of Science ®Google Scholar
• Farré, L., Y. Fawaz, L. González, and J. Graves. 2022. “Gender Inequality in Paid and Unpaid Work During COVID-19 Times.” Review of Income and Wealth 68 (2): 323–347. doi:10.1111/roiw.12563.
   Web of Science ®Google Scholar
• Fernández-Villaverde, J., and C. I. Jones. 2020. “Macroeconomic Outcomes and COVID-19: A Progress Report”. Brookings Papers on Economic Activity, 2020
   Google Scholar
• INE. 2021. Población por edad (grupos quinquenales).
   Google Scholar
• Josa-Laorden, C., A. Crestelo-Vieitez, M. D. M. Garcia Andreu, M. Rubio-Rivas, M. Sánchez, N. Toledo Samaniego, F. Arnalich Fernández, et al. 2021. “… and SEMI-COVID-19 Network.” Journal of Clinical Medicine 10 (5): 899. doi:10.3390/jcm10050899.
   PubMedGoogle Scholar
• Kerekes, S., M. Ji, S. F. Shih, H. Y. Chang, H. Harapan, Y. Rajamoorthy, A. Singh, S. Kanwar, and A. L. Wagner. 2021. “Differential Effect of Vaccine Effectiveness and Safety on COVID-19 Vaccine Acceptance Across Socioeconomic Groups in an International Sample.” Vaccines (Basel) 9 (9): 1010. doi:10.3390/vaccines9091010.
   PubMed Web of Science ®Google Scholar
• Kim, K., K. Cho, J. Song, M. Rahmati, A. Koyanagi, S. W. Lee, D. K. Yon, J. I. Shin, and L. Smith. 2023. “The Case Fatality Rate of COVID-19 During the Delta and the Omicron Epidemic Phase: A Meta-Analysis.” Journal of Medical Virology 95 (2). doi:10.1002/jmv.28522.
   Web of Science ®Google Scholar
• Lawal, L., M. Aminu Bello, T. Murwira, C. Avoka, S. Yusuf Ma’aruf, I. Harrison Omonhinmin, P. Maluleke, C. Tsagkaris, and H. Onyeaka. 2022. “Low Coverage of COVID-19 Vaccines in Africa: Current Evidence and the Way Forward.” Human Vaccines & Immunotherapeutics 18 (1): 2034457. doi:10.1080/21645515.2022.2034457.
   PubMed Web of Science ®Google Scholar
• Ling, Y., J. Zhong, and J. Luo. 2021. “Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis.” Journal of Medical Virology 93 (12): 6486–6495. doi:10.1002/jmv.27203.
   PubMed Web of Science ®Google Scholar
• Liu, Q., C. Qin, M. Liu, and J. Liu. 2021. ““Effectiveness and Safety of SARS-CoV-2 Vaccine in Real-World Studies: A Systematic Review and Meta-Analysis.” Infectious Diseases of Poverty 10 (1): 132. doi:10.1186/s40249-021-00915-3.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Y. Yu, Y. Zhao, and D. He. 2022. “Reduction in the Infection Fatality Rate of Omicron Variant Compared with Previous Variants in South Africa.” International Journal of Infectious Diseases 120: 146–149. doi:10.1016/j.ijid.2022.04.029.
   PubMed Web of Science ®Google Scholar
• Martínez-Baz, I., A. Miqueleiz, I. Casado, A. Navascués, C. Trobajo-Sanmartín, C. Burgui, M. Guevara, C. Ezpeleta, and J. Castilla. 2021. “Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection and Hospitalisation, Navarre, Spain, January to April 2021.” Eurosurveillance 26 (21). doi:10.2807/1560-7917.ES.2021.26.21.2100438.
   Web of Science ®Google Scholar
• Ministerio de Sanidad. 2021. Informe de Actividad Diario de Gestión Integral de Vacunación frente al COVID-19 en España. https://rb.gy/2p6aj7 to https://rb.gy/odjwy8
   Google Scholar
• Moghadas, S. M., T. N. Vilches, K. Zhang, C. R. Wells, A. Shoukat, B. H. Singer, L. A. Meyers, et al. 2021. “The Impact of Vaccination on COVID-19 Outbreaks in the United States.” Clinical Infectious Diseases 73 (12): 2257–2264. doi:10.1093/cid/ciab079.
   PubMed Web of Science ®Google Scholar
• Murphy, J., F. Vallières, R. P. Bentall, M. Shevlin, O. McBride, T. K. Hartman, R. McKay, et al. 2021. “Psychological Characteristics Associated with COVID-19 Vaccine Hesitancy and Resistance in Ireland and the United Kingdom.” Nature Communications 12 (1): 29. doi:10.1038/s41467-020-20226-9.
   PubMed Web of Science ®Google Scholar
• Nyberg, T., N. M. Ferguson, S. G. Nash, H. H. Webster, S. Flaxman, N. Andrews, W. Hinsley, et al. 2022. “Comparative Analysis of the Risks of Hospitalisation and Death Associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) Variants in England: A Cohort Study.” The Lancet 399 (10332): 1303–1312. doi:10.1016/S0140-6736(22)00462-7.
   PubMed Web of Science ®Google Scholar
• Ortiz-Prado, E., K. Simbaña-Rivera, L. G. Barreno, A. M. Diaz, A. Barreto, C. Moyano, V. Arcos, et al. 2021. “Epidemiological, Socio-Demographic and Clinical Features of the Early Phase of the COVID-19 Epidemic in Ecuador.” PLoS Neglected Tropical Diseases 15 (1): e0008958. doi:10.1371/journal.pntd.0008958.
   PubMed Web of Science ®Google Scholar
• Our World in Data. 2023. “Coronavirus (COVID-19) Vaccinations”. https://ourworldindata.org/covid-vaccinationsshorturl.at/aJ239
   Google Scholar
• Peres, I. T., L. Bastos, J. M. Gelli, J. F. Marchesi, L. F. Dantas, B. B. P. Antunes, P. M. Macaira, F. A. Baiao, S. Hamacher, and F. A. Bozza. 2021. “Sociodemographic Factors Associated with COVID-19 In-Hospital Mortality in Brazil.” Public Health 192: 15–20. doi:10.1016/j.puhe.2021.01.005.
   PubMed Web of Science ®Google Scholar
• Pormohammad, A., M. Zarei, S. Ghorbani, M. Mohammadi, M. H. Razizadeh, D. L. Turner, and R. J. Turner. 2021. “Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.” Vaccines (Basel) 9 (5): 467. doi:10.3390/vaccines9050467.
   PubMed Web of Science ®Google Scholar
• Razai, M. S., T. Osama, D. G. J. McKechnie, and A. Majeed 2021. “COVID-19 Vaccine Hesitancy Among Ethnic Minority Groups.” The BMJ 372: n513. re. doi:10.1136/bmj.n513.
   PubMed Web of Science ®Google Scholar
• Red Nacional de Vigilancia Epidemiológica. 2021a. Datos notificados a la RENAVE a través de SiVieS. Datos abiertos. https://rb.gy/tttmpv
   Google Scholar
• Red Nacional de Vigilancia Epidemiológica 2021b: Informes semanales sobre la situación del COVID-19 en España http://rb.gy/aosqpv
   Google Scholar
• Red Nacional de Vigilancia Epidemiológica 2021c: El Sistema de Vigilancia de la Gripe en España. https://rb.gy/0pmgnq
   Google Scholar
• Redondo-Bravo, L., M. J. S. Moros, E. V. M. Sánchez, N. Lorusso, A. C. Ubago, V. G. García, and A. Larrauri. 2020. “The First Wave of the COVID-19 Pandemic in Spain: Characterisation of Cases and Risk Factors for Severe Outcomes, as at 27 April 2020.” Eurosurveillance 25 (50): 1-13.
   Web of Science ®Google Scholar
• Saban, M., V. Myers, S. Ben-Shetrit, and R. Wilf-Miron. 2021. “Socioeconomic Gradient in COVID-19 Vaccination: Evidence from Israel.” International Journal for Equity in Health 20 (1): 1–9. doi:10.1186/s12939-021-01566-4.
   PubMed Web of Science ®Google Scholar
• Trias-Llimós, S., and U. Bilal. 2020. “Impact of the COVID-19 Pandemic on Life Expectancy in Madrid (Spain).” Journal of Public Health 42 (3): 635–636. doi:10.1093/pubmed/fdaa087.
   PubMed Web of Science ®Google Scholar
• Ward, I., C. Bermingham, D. Ayoubkhani, J. O. Gethings, K. B. Pouwels, T. Yates, K. Khunti, J. Hippisley-Cox, A. Banerjee, and A. S. Walker. 2022. “Risk of COVID-19 Related Deaths for SARS-CoV-2 Omicron (B.1.1.529) Compared with Delta (B.1.617.2): Retrospective Cohort Study.” BJM 378.
   Google Scholar